MedTrace Logo

The Effect of Colchicine on Inflammation in ACS Patients

NCT06054100 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-09-26

No results posted yet for this study

Summary

This study will evaluate whether the anti-inflammatory effect of colchicine is beneficial in ACS patients

Conditions

  • Acute Coronary Syndrome
  • STEMI

Interventions

DRUG

Colchicine Tablets

Colchicine oral tablets loading dose of 1mg every 12 hrs for 1 day, followed by 0.5 mg BID for 3 months

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Marwa A Ahmed, Phd · Faculty of Pharmacy, Ain Shams University

  • Lamia El Wakeel, Phd · Faculty of Pharmacy, Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2022-02-15
Completion
2022-05-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054100 on ClinicalTrials.gov